PROVECTUS BIOPHARMACEUTICALS, INC.: 10-Q filed 2014-08-07
What PROVECTUS BIOPHARMACEUTICALS, INC. reported in its quarterly report filed 2014-08-07 (fiscal Q2 2014): 26 published measures, 99 facts as tagged in accession 0001193125-14-299064.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2014-08-07
- Fiscal period
- fiscal Q2 2014
- Accession
- 0001193125-14-299064 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All PROVECTUS BIOPHARMACEUTICALS, INC. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-06-30 | 22,098,985 | USD | |
| At 2013-12-31 | 20,008,184 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-06-30 | 2,119,428 | USD | |
| At 2013-12-31 | 13,379,518 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-06-30 | 19,979,557 | USD | |
| At 2013-12-31 | 6,628,666 | USD | |
| At 2012-12-31 | 4,393,484 | USD | |
| At 2011-12-31 | 10,019,740 | USD | |
| At 2010-12-31 | 10,699,573 | USD | |
| At 2009-12-31 | 9,406,510 | USD | |
| At 2008-12-31 | 10,055,536 | USD | |
| At 2007-12-31 | 14,831,510 | USD | |
| At 2006-12-31 | 15,522,400 | USD | |
| At 2005-12-31 | 14,387,141 | USD | |
| At 2004-12-31 | 9,161,701 | USD | |
| At 2003-12-31 | 10,251,052 | USD | |
| At 2002-12-31 | 11,723,580 | USD | |
| At 2002-04-23 | 802 | USD | |
| At 2002-01-31 | 0 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-06-30 | 18,126,036 | USD | |
| At 2013-12-31 | 15,696,243 | USD | |
| At 2013-06-30 | 4,636,020 | USD | |
| At 2012-12-31 | 1,221,701 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-04-01 to 2014-06-30 | -643,416 | USD | 91 |
| 2014-01-01 to 2014-06-30 | -7,310,683 | USD | 181 |
| 2002-02-01 to 2014-06-30 | -153,361,503 | USD | 4533 |
| 2002-01-18 to 2014-06-30 | -153,361,503 | USD | 4547 |
| 2013-01-01 to 2013-12-31 | -27,697,744 | USD | 365 |
| 2013-04-01 to 2013-06-30 | -2,377,373 | USD | 91 |
| 2013-01-01 to 2013-06-30 | -6,547,555 | USD | 181 |
| 2012-01-01 to 2012-12-31 | -12,568,354 | USD | 366 |
| 2011-01-01 to 2011-12-31 | -19,434,699 | USD | 365 |
| 2010-01-01 to 2010-12-31 | -18,552,102 | USD | 365 |
| 2009-01-01 to 2009-12-31 | -12,322,314 | USD | 365 |
| 2008-01-01 to 2008-12-31 | -10,269,571 | USD | 366 |
| 2007-01-01 to 2007-12-31 | -10,005,631 | USD | 365 |
| 2006-01-01 to 2006-12-31 | -8,870,579 | USD | 365 |
| 2005-01-01 to 2005-12-31 | -11,763,853 | USD | 365 |
| 2004-01-01 to 2004-12-31 | -4,344,525 | USD | 366 |
| 2003-01-01 to 2003-12-31 | -3,155,313 | USD | 365 |
| 2002-04-24 to 2002-12-31 | -5,749,937 | USD | 252 |
| 2002-01-18 to 2002-04-23 | -1,316,198 | USD | 96 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-06-30 | -6,268,093 | USD | 181 |
| 2002-02-01 to 2014-06-30 | -92,175,185 | USD | 4533 |
| 2013-01-01 to 2013-06-30 | -4,945,316 | USD | 181 |
Capital expenditure payments
Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2002-02-01 to 2014-06-30 | 96,570 | USD | 4533 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-06-30 | 8,697,886 | USD | 181 |
| 2002-02-01 to 2014-06-30 | 109,844,421 | USD | 4533 |
| 2013-01-01 to 2013-06-30 | 8,359,635 | USD | 181 |
Investing cash flow
Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2002-02-01 to 2014-06-30 | 456,800 | USD | 4533 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-06-30 | -153,361,503 | USD | |
| At 2013-12-31 | -146,050,820 | USD |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-06-30 | 26,681 | USD | |
| At 2013-12-31 | 30,113 | USD |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-04-01 to 2014-06-30 | -4,159,884 | USD | 91 |
| 2014-01-01 to 2014-06-30 | -8,541,491 | USD | 181 |
| 2002-01-18 to 2014-06-30 | -137,619,128 | USD | 4547 |
| 2013-04-01 to 2013-06-30 | -3,286,835 | USD | 91 |
| 2013-01-01 to 2013-06-30 | -6,533,534 | USD | 181 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-06-30 | 18,126,036 | USD | |
| At 2013-12-31 | 15,696,243 | USD |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-06-30 | 816,467 | USD | |
| At 2013-12-31 | 512,946 | USD |
Net finite-lived intangible assets
Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-06-30 | 3,919,268 | USD | |
| At 2013-12-31 | 4,254,828 | USD |
Common-stock repurchase payments
Cash paid to reacquire common stock during the period. This is not an authorization limit or a direct measure of the net change in share count.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2002-02-01 to 2014-06-30 | 48,000 | USD | 4533 |
Gross profit
Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2002-01-18 to 2014-06-30 | 24,541 | USD | 4547 |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-04-01 to 2014-06-30 | 1,025,535 | USD | 91 |
| 2014-01-01 to 2014-06-30 | 2,183,418 | USD | 181 |
| 2002-01-18 to 2014-06-30 | 48,877,826 | USD | 4547 |
| 2013-04-01 to 2013-06-30 | 778,349 | USD | 91 |
| 2013-01-01 to 2013-06-30 | 1,518,865 | USD | 181 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-06-30 | 176,638,439 | shares | |
| At 2013-12-31 | 159,751,724 | shares |
Additional paid-in capital
Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-06-30 | 173,164,422 | USD | |
| At 2013-12-31 | 152,519,701 | USD |
Accumulated depreciation on property, plant and equipment
Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-06-30 | 432,763 | USD | |
| At 2013-12-31 | 429,331 | USD |
Other noncurrent assets
Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-06-30 | 27,000 | USD | |
| At 2013-12-31 | 27,000 | USD |
Net income available to common stockholders
Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-04-01 to 2014-06-30 | -643,416 | USD | 91 |
| 2014-01-01 to 2014-06-30 | -7,310,683 | USD | 181 |
| 2002-01-18 to 2014-06-30 | -165,388,213 | USD | 4547 |
| 2013-04-01 to 2013-06-30 | -2,450,397 | USD | 91 |
| 2013-01-01 to 2013-06-30 | -7,697,513 | USD | 181 |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-04-01 to 2014-06-30 | 2,966,569 | USD | 91 |
| 2014-01-01 to 2014-06-30 | 6,022,513 | USD | 181 |
| 2002-01-18 to 2014-06-30 | 80,969,666 | USD | 4547 |
| 2013-04-01 to 2013-06-30 | 2,340,706 | USD | 91 |
| 2013-01-01 to 2013-06-30 | 4,679,109 | USD | 181 |
Depreciation expense
Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-06-30 | 3,432 | USD | 181 |
| 2002-02-01 to 2014-06-30 | 455,764 | USD | 4533 |
| 2013-01-01 to 2013-06-30 | 3,100 | USD | 181 |
Amortization of intangible assets
Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-04-01 to 2014-06-30 | 167,780 | USD | 91 |
| 2014-01-01 to 2014-06-30 | 335,560 | USD | 181 |
| 2002-02-01 to 2014-06-30 | 7,796,177 | USD | 4533 |
| 2002-01-18 to 2014-06-30 | 7,796,177 | USD | 4547 |
| 2013-04-01 to 2013-06-30 | 167,780 | USD | 91 |
| 2013-01-01 to 2013-06-30 | 335,560 | USD | 181 |
Inspect the source
- Entity
- PROVECTUS BIOPHARMACEUTICALS, INC. / CIK 0000315545
- Captured
- 2026-09-19T14:56:22.911Z
- SEC response SHA-256
5c46f06a9f23badc21fb49ef63f53fb89ac39f7570babcbf8a64cddf67fb05d2
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0000315545.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))